In this episode we continue with our 2019/20 Summer Series, where we take a shallow-dive into companies that have been selected by the Equity Mates community. We had 180 submissions for companies to explore, so randomly picked 10. The idea of these episodes is to show how you can begin to research a company, where to look for information and what are some of the key things to consider.For this episode we are looking at a Volpara Health Technologies (ASX: VHT). This company is on the forefront of breast cancer analytics and diagnostics and is trying to both (1) win the scientific argument over its techniques and (2) create a successful business.In this episode we:discuss what the company doesunpack the scientific debate around Volpara's technologytake a look at their financial position and financial summarybreakdown some key elements of their business modelhave a crack at a valuationclose with a fun factWant more? Subscribe to Equity Mates Investing Podcast, social media channels, Thought Starters mailing list and more here.Equity Mates is a part of the Diamantina Media Network - the home of Australia's favourite podcasts. For more information, visit http://diamantina.com.au/ Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.